文献速递腹部MR

肝细胞分数与扩散加权成像联合预测定量肝纤维化评估

Combination of hepatocyte fraction and diffusion-weighted imaging as a predictor in quantitative hepatic fibrosis evaluation.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

该前瞻性研究纳入281例乙型/丙型肝炎患者,行钆塞酸二钠增强T1 mapping和扩散加权成像,评估肝细胞分数(HepF)与表观扩散系数(ADC)联合诊断肝纤维化分期的效能。结果显示HepF联合ADC诊断>S0、>S1、>S2、>S3期的AUC为0.84-0.95,高于单独HepF(0.79-0.92)或ADC(0.82-0.89)。

要点

  • HepF联合ADC对肝纤维化各期诊断AUC达0.84-0.95,优于单独指标。
  • HepF和ADC均为>S0至>S3期的独立预测因子。
  • 所有测量指标观察者间一致性良好(ICC≥0.75)。

核心结论

  • HepF与ADC联合预测因子在肝纤维化分期中表现出可接受的诊断效能。

研究设计与样本

  • 前瞻性研究,纳入281例乙型/丙型肝炎患者,行钆塞酸二钠增强T1 mapping和扩散加权成像,最终分析167例不同肝纤维化分期患者;采用逻辑回归分析独立预测因子,ROC曲线比较诊断效能,ICC评估观察者间可重复性。

诊断标准与关键数值

  • HepF联合ADC诊断>S0、>S1、>S2、>S3期的AUC为0.84-0.95;单独HepF的AUC为0.79-0.92;单独ADC的AUC为0.82-0.89。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the performance of the combined hepatocyte fraction (HepF) and apparent diffusion coefficient (ADC) values to stage hepatic fibrosis (HF) in patients with hepatitis B/C.

MATERIALS AND METHODS: A total of 281 patients with hepatitis B/C prospectively underwent gadoxetate disodium-based T1 mapping and diffusion-weighted imaging. HepF was determined from pre and postcontrast T1 mapping with pharmacokinetics. The independent predictors of the HF stage (S0-4) were identified from HepF, ADC, conventional T1-based parameters, and age using a logistic regression analysis. The performances of independent and combined predictors in diagnosing various HF stages were compared by analyzing receiver operating characteristic curves. The intraclass correlation coefficient (ICC) was used to assess the interobserver reproducibility of each predictor.

RESULTS: In total, 167 patients with various stages of HF were included. All measurements had excellent interobserver agreement (ICC ≥ 0.75). The hepatic relative enhancement, HepF ,and ADC values were significantly different among various HF stages (p < 0.05). The HepF and ADC were independent predictors of > S0, > S1, > S2 , and > S3 disease (p < 0.05). T1Liver, T1Spleen, and T1Liver/Spleen were independent predictors of S > 2 disease (p < 0.05). The performance of HepF combined with the ADC (area under the curve (AUC) = 0.84-0.95) was higher than HepF (AUC = 0.79-0.92) or ADC (AUC = 0.82-0.89) alone in diagnosing > S0, > S1, > S2 , and > S3 disease.

CONCLUSION: The combined predictor of HepF and ADC shows acceptable performance for staging HF.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Cui E, Li Q, Wu J, et al. Combination of hepatocyte fraction and diffusion-weighted imaging as a predictor in quantitative hepatic fibrosis evaluation. Abdom Radiol (NY). 2020. PMID: 32266505. doi:10.1007/s00261-020-02520-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。